yingweiwo

Factor Xa

Factor Xa

Factor Xa related products

Structure Cat No. Product Name CAS No. Product Description
ARC19499 sodium V129362 ARC19499 sodium ARC19499 sodium is an aptamer that inhibits tissue factor pathway inhibitors (TFPIs), thereby promoting the initiation and propagation of the extrinsic coagulation pathway.
Boc-Ile-Glu-Gly-Arg-AMC (IEGR-AMC) V73150 Boc-Ile-Glu-Gly-Arg-AMC (IEGR-AMC) 65147-06-0 Boc-Ile-Glu-Gly-Arg-AMC (IEGR-AMC) is an activating factor X (FXa)-specific fluorescent peptide substrate for the determination of factor VIII.
DX-9065a free base V115300 DX-9065a free base 150612-55-8 DX-9065a free base is a selective, non-peptide, orally effective factor Xa (FXa) inhibitor with a Ki value of 41 nM for human FXa.
FXa-IN-1 V73141 FXa-IN-1 441328-10-5 FXa-IN-1 is an FXa inhibitor (IC50= 3 nM, Ki: 0.7 nM) with considerable oral bioavailability (F) and half-life (in vivo).
Zemocimig V147311 Zemocimig 2955620-21-8 Zemocimig is a human IgG4κ monoclonal antibody against coagulation factor F9.
伊多塞班 V2615 Edoxaban 480449-70-5 Edoxaban (alsoknown as DU-176b; DU176; Lixiana; Savaysa)is a potent, direct-acting, selective, orally bioavailable factor Xa inhibitor used as ananticoagulant drug.
利伐沙班 V0948 Rivaroxaban (BAY 59-7939) 366789-02-8 Rivaroxaban (BAY59-7939; BAY-59-7939;trade name: Xarelto),an approved anticoagulant drug used to treat and prevent blood clots, is the first orally bioavailable, selective anddirect inhibitor of Factor Xa with potential anti-coagulant activity.
利伐沙班R-对映体 V4340 R-ENANTIOMER OF RIVAROXABAN 865479-71-6 5-R-Rivaroxaban is (R)-enantiomer of Rivaroxaban (also known as BAY 59-7939) which is the first orally available,direct inhibitor of Factor Xa with Ki and IC50 of 0.4 nM and 0.7 nM in cell-free assays, respectively.
甲磺酸依度沙班一水合物 V0950 Edoxaban tosylate monohydrate (DU-176b) 1229194-11-9 Edoxaban tosylate monohydrate(DU-176b;DU-176; trade name Lixiana), the tosylate salt of edoxaban which is a marketed anticoagulant drug,is a potent, selective, orally bioavailable anddirect factor Xa inhibitor with potential anti-coagulant activity.
阿哌沙班 V0949 Apixaban (BMS-56224701) 503612-47-3 Apixaban (formerlyBMS56224701; BMS 56224701;BMS-56224701; trade name: Eliquis),an approved drug used to treat and prevent the formation of blood clots, is a highly selective, reversible, direct inhibitor of Factor Xa with potential anti-coagulant activity.
Contact Us